Nasdaq-listed medical device technology company BioSig Technologies has announced a merger with Streamex Exchange Corporation, another Nasdaq-listed company, and has also signed a financing agreement of up to $1.1 billion to advance the development of its RWA tokenization business. The company will sell $100 million in senior secured convertible notes and a $1.0 billion equity line of credit, with Tether asset custodian Cantor Fitzgerald acting as co-lead placement agent for the deal. [Wu Shuo]

U.S.-listed medical device technology company BioSig Technologies is merging with another publicly traded company, Streamex Exchange Corporation, while also signing a $1.1 billion financing agreement to advance the development of RWA tokenization business, promote the on-chaining of the $142 trillion commodity market, and focus on gold tokenization. The company will sell $100 million worth of senior secured convertible bonds and a $1 billion equity line of credit. Tether asset custodian Cantor Fitzgerald will serve as the joint lead placement agent for the deal. [Foresight News]

U.S.-listed medical device technology company BioSig merges with Streamex, plans to raise $1.1 billion to advance RWA tokenization development

According to Businesswire, Nasdaq-listed medical device technology company BioSig Technologies has announced a merger with another Nasdaq-listed company, Streamex Exchange Corporation. The company has also signed a financing agreement of up to $1.1 billion to advance the development of its RWA tokenization business, promote the on-chaining of the $142 trillion commodity market, and focus on gold tokenization. It is reported that the company will sell $100 million worth of senior secured convertible bonds and a $1.0 billion equity credit line. Tether asset custodian Cantor Fitzgerald will serve as the joint lead placement agent for the transaction. [ChainCatcher]

BioSig Technologies Merges with Streamex Exchange Corporation and Signs $1.1 Billion Financing Agreement to Promote RWA Tokenization

On July 8, BioSig Technologies, a US-based medical device technology company listed on Nasdaq, announced that it has merged with Streamex Exchange Corporation, another Nasdaq-listed company. It also signed a financing agreement of up to $1.1 billion to promote the development of RWA tokenization business, promote the on-chaining of the $142 trillion commodity market, and focus on gold tokenization.

The company will sell $100 million worth of senior secured convertible bonds and a $1 billion equity credit line. Tether's asset custodian, Cantor Fitzgerald, is the joint lead placement agent for the transaction.

Streamex is a wholly-owned subsidiary of BioSig Technologies, Inc. and is a real-world asset (RWA) tokenization company focused on the commodity sector. Streamex aims to put the commodity market on-chain and has developed key issuance and trading infrastructure that will revolutionize commodity finance. [BlockBeats]

USDT

BioSig Merges with Streamex, Plans to Raise $1.1 Billion to Advance RWA Tokenization Development

On July 8, BioSig Technologies, a U.S. Nasdaq-listed medical device technology company, announced that it has merged with Streamex Exchange Corporation, another Nasdaq-listed company, and also signed a financing agreement of up to $1.1 billion to promote the development of RWA tokenization business, promote the on-chaining of the $142 trillion commodity market, and focus on gold tokenization.

The company will sell $100 million worth of senior secured convertible bonds and a $1 billion equity credit line. The transaction is co-led by Cantor Fitzgerald, the asset custodian of Tether.

Streamex is a wholly-owned subsidiary of BioSig Technologies, Inc. and is a real-world asset (RWA) tokenization company focused on the commodity sector. Streamex's goal is to put the commodity market on-chain and has developed key issuance and trading infrastructure that will revolutionize commodity finance. [BlockBeats]

Publicly Listed BioSig Merges with Streamex, Plans to Raise $1.1 Billion to Advance RWA Tokenization Development

Publicly Listed BioSig to Merge with Streamex, Planning to Raise $1.1 Billion to Support RWA Tokenization

On July 8 (UTC+8), Nasdaq-listed medical device technology company BioSig Technologies announced that it has merged with another Nasdaq-listed company, Streamex Exchange Corporation, and has also signed a financing agreement of up to $1.1 billion to promote the development of RWA tokenization business, promote the on-chaining of the $142 trillion commodity market, and focus on gold tokenization. (Source: Bitpush) [MetaEra]

Publicly Listed BioSig Merges with Streamex, Plans to Raise $1.1 Billion to Support RWA Tokenization, Cantor Fitzgerald Leads Placement Agent

Nasdaq-listed medical device technology company BioSig Technologies has announced a merger with Streamex Exchange Corporation, another Nasdaq-listed company, and has also signed a financing agreement of up to $1.1 billion to advance the development of its RWA tokenization business, promote the on-chaining of the $142 trillion commodity market, and focus on gold tokenization. It is reported that the company will sell $100 million worth of senior secured convertible bonds and a $1.0 billion equity line of credit. Tether asset custodian Cantor Fitzgerald is acting as the joint lead placement agent for the deal. (Businesswire) [Odaily Planet Daily]

Publicly traded company BioSig merges with Streamex, planning to raise $1.1 billion to support RWA tokenization, with Cantor Fitzgerald leading the placement agent.

纳斯达克上市的医疗设备技术公司 BioSig Technologies 宣布将与另一家纳斯达克上市公司 Streamex Exchange Corporation 合并，并签署了一项最高达11亿美元的融资协议，以推动其 RWA 代币化业务的发展。该公司将发行1亿美元的高级有担保可转换债券及10亿美元的股权融资额度，Tether资产托管方 Cantor Fitzgerald 担任此次交易的联合主承销商。

上市公司BioSig计划与Streamex合并，筹集11亿美元以支持RWA代币化

納斯達克上市的醫療設備技術公司 BioSig Technologies 宣佈將與另一家納斯達克上市公司 Streamex Exchange Corporation 合併，並簽署了一項最高達11億美元的融資協議，以推動其 RWA 代幣化業務的發展。該公司將發行1億美元的高級有擔保可轉換債券及10億美元的股權融資額度，Tether資產託管方 Cantor Fitzgerald 擔任此次交易的聯合主承銷商。